Orthobiologics for Hamstring Injuries: What PRP and PPP Can (and Cannot) Add to Your Recovery

Hamstring injuries are common in active patients and athletes, and recovery timing can make or break a season. Orthobiologics such as platelet-rich plasma (PRP) and platelet-poor plasma (PPP) are being used more often to support healing. This blog summarizes the most positive data available, while also being clear about limitations.

 

What Are PRP and PPP?

• PRP: Your own blood is spun to concentrate platelets and their growth factors, then injected at the injury site. These factors can support tissue repair, blood vessel formation, and early cell proliferation.¹ ²
• PPP: The leftover plasma after most platelets are removed. PPP is relatively richer in factors that modulate inflammation and promote muscle regeneration and differentiation, with potentially less scar formation than PRP.²

Both are considered “orthobiologics” – treatments that use your own biology to assist healing.

What Does the Most Positive PRP Research Show?

Several randomized trials and cohort studies report faster return to play (RTP), less pain, or lower reinjury when PRP is added to high-quality rehab:

• A randomized trial of MRI-confirmed grade 2 hamstring injuries found that athletes receiving ultrasound-guided PRP plus standardized therapy returned to play in 26.4 ± 4.5 vs 34.2 ± 5.7 days with rehab alone, with improved MRI healing at 21 days.³
• Another RCT in acute grade 2 hamstring injuries showed PRP + rehab led to RTP at 26.7 ± 7.0 vs 42.5 ± 20.6 days in rehab-only controls, with lower pain severity over time.⁴
• A meta-analysis focused on hamstring injuries reported that PRP + physical therapy shortened RTP by approximately 2–4 days and trended toward lower reinjury risk, though protocol variability limits certainty.⁵ ⁶
• Broader meta-analyses of acute muscle strains (including hamstrings) found PRP can shorten RTP by 5–7 days overall, though benefits are less consistent in strict double-blind or hamstring-only analyses.⁷ ⁸
• A large NFL cohort found PRP did not reduce total days or practices missed, but did reduce games missed (1.3 vs 2.9), a potentially meaningful difference at the professional level.⁹
• In athletes with proximal hamstring tendinopathy, PRP injections significantly reduced pain and functional limitation after failed conservative care, with return to desired activity.¹⁰
• A systematic review of acute soft-tissue injuries reported earlier recovery and lower pain in hamstring RCTs using PRP compared with controls.¹¹
• A systematic review focused on athletes found PRP may improve early pain and recovery, though evidence quality remains mixed.¹²
• A cohort combining hematoma aspiration and PRP injection for grade 2 hamstring strains reduced RTP from 32.4 to 23.5 days and reinjury from 28.6% to <4%.¹³
• In professional football players, intralesional PRP for grade 2 hamstring injuries resulted in low reinjury (12%) and MRI evidence of high-quality repair tissue.¹⁴

Overall, PRP-favorable studies suggest modest acceleration of RTP (often 1–2 weeks) and possible reductions in pain and reinjury risk.³ ⁴ ⁵ ⁷ ⁹ ¹¹ ¹³ ¹⁴

 

What About PPP?

PPP is newer in clinical use, but early evidence is encouraging:

• A cohort of collegiate football athletes treated with PPP for acute hamstring strains showed an average RTP of 29.4 ± 7.2 days with no reinjuries at 12 months and early pain improvement.¹⁵
• In a three-arm RCT (PRP vs PPP vs no injection), PRP led to RTP approximately 5.7 days sooner than PPP, though PRP was not clearly superior to no injection.¹⁶
• Mechanistic and narrative data suggest PPP may better support muscle regeneration and controlled inflammation, with potential theoretical reductions in fibrosis, though comparative trials remain limited.²

 

PPP appears safe and potentially helpful but remains more “emerging” than PRP from an evidence standpoint.² ¹⁵

 

How Orthobiologic Evidence Fits Into Real-World Decision-Making

 

1. Orthobiologics Are an Adjunct to, Not a Replacement for, Rehab

All positive studies combined injections with structured rehabilitation. Eccentric strengthening, muscle-lengthening exercises, and trunk stabilization remain foundational.⁵ ⁷ ¹

2. Individualized Treatment: No “One-Size-Fits-All”

At a practice such as drjazortho.com, treatment would be individualized based on:

• Type and severity of injury
  Injury grade, location, and tissue involvement strongly influence prognosis and biologic decision-making.³ ⁴ ¹³ ²⁰
• Athlete’s competitive level and timing
  In professional settings, even a single game earlier return can be clinically and financially meaningful.⁹
• History of prior injury or tendinopathy
  PRP has shown particular promise for chronic proximal hamstring pain after failed conservative care.¹⁰
• Patient values and risk tolerance
  PRP and PPP are minimally invasive with low complication rates, but benefits are typically incremental rather than dramatic.⁶ ⁷

Setting Realistic Expectations

 

Even among the most positive studies:

• RTP improvements are generally 5–15 days, not months.³ ⁵ ⁷ ¹³
• Not all trials show superiority over placebo or control injections.⁶ ⁷ ¹⁸ ¹⁹ ²⁰
• Reinjury reductions, when present, are modest trends rather than guarantees.⁵ ⁹ ¹³ ¹⁴

 

Bottom Line for Patients

• PRP and PPP may modestly speed return to sport and reduce pain when paired with high-quality rehabilitation.³ ⁵ ⁷ ⁹ ¹¹ ¹³ ¹⁴ ¹⁵
• Evidence is strongest for acute grade 2 muscle strains and chronic proximal hamstring tendinopathy.³ ⁴ ¹³ ¹⁰
• PPP is an emerging option with promising early data but fewer high-quality trials.² ¹⁵
• Orthobiologic decisions should always be individualized in partnership with a sports medicine specialist.

 

References:

1. Hamid MSA, Hussein KH, Salim A, et al. Study protocol for a double-blind randomized controlled trial evaluating platelet-rich plasma injection for acute grade-2 hamstring tears. BMJ Open. 2020;10.
2. De Araújo Moury Fernandes G, Rodeo SA. Platelet-poor plasma for muscle injuries: Mechanisms and clinical perspectives. Orthop J Sports Med. 2025;13.
3. Desouza C, Shetty V. Efficacy of platelet-rich plasma in grade 2 hamstring muscle injuries: Results from a randomized controlled trial. Eur J Orthop Surg Traumatol. 2025.
4. Hamid MSA, Ali MR, Yusof A, George J, Lee LPC. Platelet-rich plasma injections for the treatment of hamstring injuries. Am J Sports Med. 2014;42:2410–2418.
5. Liu M, Zhai H, Wang R, Wang J, Xiong Y, Peng Y. Effect of platelet-rich plasma injection in hamstring injury: A systematic review and meta-analysis. J Sport Rehabil. 2025.
6. Seow D, Shimozono Y, Yusof T, Yasui Y, Massey A, Kennedy J. Platelet-rich plasma injection for the treatment of hamstring injuries: A systematic review and meta-analysis. Am J Sports Med. 2020;49:529–537.
7. Grassi A, Napoli F, Romandini I, et al. Is platelet-rich plasma effective in acute muscle injuries? A systematic review and meta-analysis. Sports Med. 2018;48:971–989.
8. Sheth U, Dwyer T, Smith I, et al. Does platelet-rich plasma lead to earlier return to sport in acute muscle injuries? A systematic review and meta-analysis. Arthroscopy. 2018;34:281–288.e1.
9. Bradley JP, Lawyer TJ, Ruef S, Towers JD, Arner JW. Platelet-rich plasma shortens return to play in National Football League players with acute hamstring injuries. Orthop J Sports Med. 2019;8.
10. Wetzel R, Patel R, Terry MA. Platelet-rich plasma as an effective treatment for proximal hamstring injuries. Orthopedics. 2013;36:e64–e70.
11. O’Dowd A. Update on the use of platelet-rich plasma injections in musculoskeletal injuries: A systematic review (2014–2021). Orthop J Sports Med. 2022;10.
12. De Sire A, Marotta N, Prestifilippo E, et al. Efficacy of platelet-rich plasma injection for pain relief in injured athletes: A systematic review of randomized controlled trials. J Sports Med Phys Fitness. 2025.
13. Trunz L, Landy J, Dodson CC, et al. Effectiveness of hematoma aspiration and platelet-rich plasma injections for hamstring strains in athletes. Med Sci Sports Exerc. 2021;54:12–17.
14. Zanon G, Combi F, Combi A, et al. Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players. Joints. 2016;4:17–23.
15. Kruse RC, Volfson E. Platelet-poor plasma for acute hamstring injuries in collegiate football athletes: A cohort study. Clin J Sport Med. 2024.
16. Hamilton B, Tol JL, Almusa E, et al. Platelet-rich plasma does not enhance return to play in hamstring injuries: A randomized controlled trial. Br J Sports Med. 2015;49:943–950.
17. Poursalehian M, Lotfi M, Zafarmandi S, Bahri R, Halabchi F. Hamstring injury treatments and management in athletes. JBJS Rev. 2023;11.
18. Reurink G, Goudswaard GJ, Moen MH, et al. Rationale and 1-year follow-up of PRP injections in acute hamstring injury: The Dutch HIT study. Br J Sports Med. 2015;49:1206–1212.
19. Guillodo Y, Madouas G, Simon T, Dauphin H, Saraux A. Platelet-rich plasma treatment of severe acute hamstring injuries. Muscles Ligaments Tendons J. 2015;5:284–288.
20. González-Iglesias J, Lekue J, Larruskain J, et al. Platelet-rich plasma injections for acute hamstring muscle injuries: A randomized controlled trial in soccer players. Sports Orthop Traumatol. 2023.